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Introduction: Recent evidence has shown that bone marrow cells play critical roles during the inflammatory,
proliferative and remodeling phases of cutaneous wound healing. Among the bone marrow cells delivered to
wounds are stem cells, which can differentiate into multiple tissue-forming cell lineages to effect, healing. Gaining
insight into which lineages are most important in accelerating wound healing would be quite valuable in designing
therapeutic approaches for difficult to heal wounds.
Methods: In this report we compared the effect of different bone marrow preparations on established in vitro
wound healing assays. The preparations examined were whole bone marrow (WBM), whole bone marrow (long
term initiating/hematopoietic based) cultured cells (BMC), and bone marrow derived mesenchymal stem cells
(BM-MSC). We also applied these bone marrow preparations in two murine models of radiation induced delayed
wound healing to determine which had a greater effect on healing.
Results: Angiogenesis assays demonstrated that tube formation was stimulated by both WBM and BMC, with WBM
having the greatest effect. Scratch wound assays showed higher fibroblast migration at 24, 48, and 72 hours in
presence of WBM as compared to BM-MSC. WBM also appeared to stimulate a greater healing response than BMC
and BM-MSC in a radiation induced delayed wound healing animal model.
Conclusions: These studies promise to help elucidate the role of stem cells during repair of chronic wounds and
reveal which cells present in bone marrow might contribute most to the wound healing process.Introduction
Conditions such as diabetes, chronic renal failure, arterial
or venous insufficiency, and radiation-induced tissue dam-
age are among the multifactorial processes that contribute
significantly to dysfunctional wound healing [1-3]. These
complex wounds are characterized by inhibition of the in-
flammatory response, dysfunctional macrophages leading
to an inability to combat infection, impaired angiogenesis
and vasculogenesis, accumulation of fibrous tissue, and
aberrant extracellular matrix accumulation [4]. Numerous
therapies have been attempted to treat chronic wounds.
Approaches promoting healing such as debridement, fre-
quent dressing changes, antibiotic therapy, and increasing* Correspondence: ebadiavas@med.miami.edu
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efficacy [3,4].
Recent studies have shown that the regenerative po-
tential of stem cells may be applicable to the treatment
of healing chronic wounds [5]. Using somatic stem cells
rather than embryonic stem cells paves the way for a
treatment that is limited in ethical concerns. Bone mar-
row has been used as a source of cellular therapy be-
cause it contains inflammatory cell progenitors long
identified as being important in wound healing as well
as mesenchymal stem cells, and other multipotent stem
cells [6]. Mesenchymal stem cells have the potential to
rebuild the dermis by differentiating into many cell types
such as fibroblasts, cartilage and muscle [3]. These cells
can also release many growth factors and cytokines that
are vital to wound repair. Other multipotent cells, such
as hematopoietic stem cells and vascular progenitors,Med Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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significantly to wound repair [7].
The multipotent capability of bone marrow cells gave
an impelling reason to study the role of bone marrow in
chronic wound healing and several clinical studies have
reported on its benefit [8]. Studies comparing these
preparations are, however, needed in order to begin
examining which cell types and preparations may be
most beneficial in designing improved treatment proto-
cols. We have utilized mouse models to investigate the
effectiveness of whole bone marrow (WBM), whole bone
marrow (long term initiating/hematopoietic based) cul-
tured cells (BMC), and bone marrow derived mesenchy-
mal stem cells (BM-MSC) in both in vitro and in vivo
murine wound healing models. The in vitro models we
studied included angiogenesis and scratch migration as-
says. For in vivo models we utilized two models of radi-
ation induced delayed wound healing. In the more
standard model, split dose not ablative radiation was ad-
ministered to animals prior to creating wounds and ad-
ministering cells. In another ‘reverse’ model, wounding
was performed between the split doses of non-ablative
radiation and cells applied after all radiation doses were
given. Wound healing was delayed to a greater extent in
the reverse model. The availability of transgenic C57/
BL6 mice expressing GFP in all tissues provides the op-
portunity to deliver and track donor cells in non-GFP
recipient mice. The percentage of wound closure, en-
graftment and stimulation of wound healing were among
the endpoints evaluated.
Methods
Mice and isolation of whole bone marrow (WBM)
Recipient four-week-old female C57BL/6 mice and
donor male GFP+ transgenic C57BL/6(SJL)-Tg(UBC-
GFP,-TVA)1Clc/J mice were obtained from Jackson
Laboratories, Bar Harbor, ME, USA. The Institutional
Animal Care and Use Committee approved the experi-
mental protocol for these studies. Isolation of whole bone
marrow cells from compact bone of C57BL/6-Tg (UBC-
GFP) mice was done using the protocol provided by Stem
Cell Technologies Inc., Vancouver, Canada. Cat No 28453.
After the whole bone marrow was isolated it was cryopre-
served and placed in liquid nitrogen freeze storage tanks.
Whole bone marrow cultured cells
The WBM cultures utilized here are long term initiating
cultures, which are capable of retaining functional primi-
tive hematopoietic stem and progenitor cells for many
weeks [9]. To create these cultures, freshly isolated WBM
from GFP+ transgenic C57BL/6-Tg (UBC-GFP) male
donor mice was cultured as previously described [2]. Cul-
tures were incubated at 33°C and 5% CO2 in 225 cm
2
Corning flasks and were fed weekly without removing anyof the previous media. These cultures have been demon-
strated to have clinical benefit in treating recalcitrant
chronic wounds in patients [2]. In order to be consistent
with previous clinical studies, these cells were harvested
fresh for each experiment after four weeks of culture.
Bone marrow derived mesenchymal stem cells
Mesenchymal stem cells were generated according to
the protocol described by Stem Cell Technologies Inc.
Cat No 28453. These methods do not support the long-
term growth of hematopoietic stem and progenitor cells.
WBM derived from C57BL/6-Tg (UBC-GFP) mice was
placed into selective media (Complete MesenCult©
Medium - Stem Cell Technologies Inc. Cat. No 05501,
05502) allowing the growth of mesenchymal stem cells.
The cells were incubated in a 225 cm2 Corning flask at
37°C and 5% carbon dioxide for 10 days. After that half
of the medium was changed and replaced with an equal
volume of Complete MesenCult© Medium. When the
cells reached approximately 80% confluence they were
expanded (expansion 1:3) to reach passage four (P4). An
Olympus fluorescent microscope and Metamorph Soft-
ware were used to determine if the BMC and BM-MSC
were healthy and expressing GFP. After five weeks of
culture, cells were harvested, counted, cryopreserved
and placed in nitrogen freezing storage tanks. In clinical
protocols utilizing these cells, they are typically adminis-
tered from cryopreserved materials [10].
Human umbilical vein endothelial cells
A human umbilical vein endothelial cell (HUVEC) line
and culture medium were obtained from Invitrogen
Catalogue/Life Technologies-NY, USA. No A1460901.
In vitro angiogenesis assay
HUVEC suspensions were seeded in 24-well plates con-
taining GeltrexTM matrix (Invitrogen) and incubated for
30 minutes at 37°C. Boyden chamber transwell inserts of
8 μm containing 104 cells corresponding to WBM,
BMC, BM-MSC and controls were then placed in indi-
vidual HUVEC seeded wells. In this experiment we used
Medium 200 containing 2% (v/v) fetal bovine serum
(FBS) and basic fibroblast growth factor (bFGF, 3 ng/μl)
as the positive control and Medium 200 (Invitrogen) as
the negative control. The 24-well plates containing in-
serts were incubated at 37°C in a humidified atmosphere
of CO2 in air for eight hours. The Boyden chamber
transwells containing bone marrow cells were then re-
moved and the wells containing HUVEC cells were
stained for 30 minutes with calcein-AM dissolved in di-
methyl sulfoxide (DMSO). The wells were then photo-
graphed using an inverted IX81 Olympus microscope
(Olympus America, Center Valley, PA, USA) and ORCA-
AG Hamamatsu digital camera (Hamamatsu Photonics
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formation was assessed using Image J software.Cell migration assay
The cell migration assay was performed using a modified
Boyden chamber (8 μm pore size) [11]. First, the mouse
fibroblasts were seeded onto 24-well dishes at a density
of 104 cells per well. The dishes were incubated to estab-
lish confluent monolayers and then treated with 10 mg/
ml mitomycin for two hours before scratch–wounding.
Cell monolayers were mechanically disrupted with a 1
mL pipette tip. After disruption, monolayers were gently
washed twice with PBS to remove cell debris. Serum-free
media (300 μl) was added to these wells (lower chamber)
containing mouse fibroblast cells. Subsequently, 104 cells
corresponding to WBM, BMC or BM-MSC were seeded
at the top of the Boyden chamber insert in 200 μl of
serum free medium and placed into wells containing
scratch-wounded fibroblasts. Wells containing 200 μl of
medium without cells were used as the negative control.
The width of the denuded surface between the edges of
defect was measured immediately after disruption and
after 24, 48 and 72 hours. Defect closing was documented
photographically (five pictures per well) using the inverted
IX91 Olympus microscope described above. The unclosed
distance (μM) between two edges at three different points
along the length of the defect was quantified as an average
gap.Wound healing model
C57BL/6 mice were used for this experiment. All mice
(n = 12) were radiated for five minutes at 80 rad/minute
in order to reduce their rate of wound closure and allow
for better engraftment of delivered cells. After a four-
hour resting stage the mice were again radiated for five
minutes at 80 rad/minute to maximize these effects.
Mice were anesthetized by i.p. injection of 87 mg/kg
ketamine and 13 mg/kg xylazine, prior to all procedures.
To create wounds, the back of the mice closest to the
tail was shaved and an 8 mm full thickness wound was
made using a punch biopsy instrument (Sklar Surgical
Instruments Corp.-PA, USA). All cells were adminis-
tered at a dose of 2 × 106 cells via tail vein injection.
Control mice were irradiated and wounded but not
injected with any cells. Classical and Reverse models dif-
fered in the timing of irradiation, wounding and cell ad-
ministration. In the Classical model, mice were first
irradiated two times, rested for 24 hours, administered
cells by tail vein injection, rested (to allow for stem cell en-
graftment) for 30 days and then wounded. For the Reverse
model, mice were irradiated once, wounded, irradiated the
second time, rested 24 hours and then administered cells.
Each group contained four wounded and irradiated mice.Morphometric analysis of wounded mice
At time zero, digital photographs were taken as soon as
the punch biopsy wound was made on the back of the
mice in order to establish a baseline. Photographs were
taken again on days 2, 4, and 7 and analyzed using the
cellSens Standard software (Olympus Corporation) to
determine the percentage of wound closure by conversion
of pixels to micrometers. The percentage of wound
closure was averaged for each treatment group.
FACS analysis
In order to establish that the animals in the classical
model retained engrafted cells at the time of wounding,
assessment of engraftment of bone marrow cells was
evaluated in peripheral blood collected from the tail
veins of mice 28 days after receiving bone marrow cells.
Non-transplanted C57BL/6 and transgenic C57BL/6-Tg
(UBC-GFP) mice served as positive and negative con-
trols. Heparinized mouse blood (0.3 mL) was centrifuged
at 1,400 g for five minutes at 4°C, and each blood sample
was incubated with 3 mL of NH4Cl, pH 7.2, for ten mi-
nutes at room temperature to lyse the red blood cells.
The remaining leukocytes were washed with phosphate-
buffered saline (PBS), pH 7.4, and flow cytometry was
carried out in the fluorescein isothiocyanate (FITC)
channel. Fluorescence-activated cell sorting (FACS) ana-
lysis of each mouse blood sample was performed to
evaluate the level of GFP chimerism. Five mice for each
group were used for FACS analysis. The results show
that more than 60% chimerism was obtained one month
after cells were transferred via tail vein injection.
Statistical analysis
To statistically analyze differences between multiple
groups at one time point, one-way analysis of variance
(ANOVA) with its subsequent Bonferroni’s multiple
comparison tests were used. Graphs and statistics were
generated using Prism version 5 for Mac OS X. A value
of P of less than 0.05 was considered statistically significant.
The quantitative results are expressed as mean +/− SEM
(standard error of the mean).
Results
Contribution of bone marrow cells in a matrigel tube
formation assay
Wound tissue regeneration is highly dependent on pro-
liferation of local cells and blood supply. The angiogenic
support provided by stem cells in this process is funda-
mental in the reestablishment of blood supply for recov-
ery of damaged tissue. We utilized an in vitro tube
formation assay to analyze the contribution of these
stem cell preparations in tissue repair (Figure 1A); for
this purpose, HUVEC cells were seeded in matrigel and
bone marrow cells (as described above) were added.
Figure 1 (See legend on next page.)
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Figure 1 Matrigel tube formation assay. (A) Schematic diagram of the tube formation assay chamber. HUVECs were seeded in 24-well plates
containing GeltrexTM matrix in the lower chamber. The upper chamber was prepared by plating a monolayer of BMC, WBM or MSC onto a very
thick layer followed by incubation at 37°C for eight hours. Following incubation, the Boyden chamber containing the cells was removed and the
plate with HUVEC cells was stained for 30 minutes with calcein-AM dissolved in DMSO. The number of tube-like structures that formed in the gel
was measured by total length per field (X 200). (B) Phase contrast micrographs show HUVECs grown in matrix gel and tubular structure induced
by different kinds of stem cells: (I) negative control (Medium 200); (II) positive control (Medium 200 containing 2%(v/v) FBS and bFGF (3 ng/μl);
(III) BMC: whole bone marrow cultured cells; (IV) whole bone marrow and (V) mesenchymal stem cells. (C) Quantitative analysis of angiogenesis
in vitro by measuring the occupied area due to the tubular structures formed by HUVECs. Photographs were taken eight hours after the HUVECs
were seeded and inserts containing the stem cells were placed in the 24 well plates. In this experiment we used Medium 200 containing 2%
(v/v) FBS and bFGF (3 ng/μl) as the positive control and Medium 200 from Invitrogen as the negative control. The induction of matrigel tube
formation is higher in the presence of WBM compared with BMC and MSC. WBM versus BMC P <0.05, WBM versus MSC P <0.05. Data are
expressed as mean +/− SEM of five measurements. bFGF, basic fibroblast growth factor; BMC, whole bone marrow cultured cells; DMSO, dimethyl
sulfoxide; FBS, fetal bovine serum; HUVECs, human umbilical vein endothelial cells; MSC, mesenchymal stem cells; SEM, standard error of the
mean; WBM, whole bone marrow.
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lated by WBM, BMC, BM-MSC and negative control
(no bone marrow cells added). We found that tube for-
mation was stimulated by both WBM and BMC with
WBM having the greater effect. The effect noted by add-
ing BM-MSC appeared to be much smaller and compar-
able to the positive control (Figure 1B).
Figure 1C shows a qualitative representation of tube
formation when the branch number is higher in the
presence of WBM compared to BMC and MSC.
Contribution of whole bone marrow compared with MSC
in a scratch assay
Cell migration is a crucial event in cutaneous wound re-
pair and understanding how stem cells influence cell mi-
gration will aid in developing protocols for improved
wound healing. To examine whether MSC, WBM or
BMC promote cell migration during wound closure, we
performed an in vitro scratch wound assay as described
above (Figure 2A). The distance between wound edges
was measured at 0, 24, 48 and 72 hours to determine
migration values (migration values = D0-DT). In the
scratch wound assay represented in Figure 2B and 2C
we observed higher fibroblast migration in the presence
of WBM or BMC as compared to MSC (P <0.01). Differ-
ences between WBM compared to BMC were also noted
to be significant (P <0.05) with WBM showing a greater
effect (Figure 2C).
Classical versus reverse model for wound healing in mice
In both the classical and reverse models we used frac-
tioned total body irradiation with a four hour interval
between doses. A significant difference between the clas-
sical and reverse wound healing models is that in the
classical model an 8 mm punch biopsy excision is made
30 days after the last radiation dose whereas in the re-
verse model the 8 mm punch is created between the two
cycles of radiation. We found that wound closure for
both models was delayed in comparison to control(untreated) mice and that wounds in the reverse model
were significantly delayed in closure compared to the
classical model. This likely is due to a more direct effect
of radiation on reducing available resident stem cells to
orchestrate repair following injury. The reverse model,
therefore, promised to give us a greater ability to exam-
ine the effects of delivered stem cells on wound closure
(Figure 3B).
Stem cells contribution to wound healing in a mouse
model
The reverse model gave us a unique opportunity to test
the ability of our three cell preparations to overcome the
significant delay in wound healing observed,
Treatment with WBM, BMC and BM-MSC showed im-
provement in wound closure over controls (Figure 4A). At
Day 7, all cell preparations appeared to improve wound
closure significantly over control with BMC and WBM
showing the greatest effect (Figure 4B). At Day 15, BMC
and WBM treated wounds were completely epithelialized
while wounds treated with MSC or given no cells were
still not fully epithelialized. The slight improvement in
WBM over BMC might be due to the increased amounts
of cytokines in a whole tissue preparation. However, this
degree of similarity in wound closure indicates that stem
and progenitor cells important for skin repair are not lost
in the process of cell culture [5]. Epithelialization of
wounds was at first (Day 2) fastest in animals treated
with WBM and later (Day 7) in animals treated with
BMC (Figure 4B). This indicates that combinations of
varied stem and progenitor cells are important in initiating
wound repair and that single stem cell types (here BM-
MSC) may be less effective. This initiation of wound re-
pair could be critical in reversing the phenotype of chronic
wounds where stem and progenitor cells appear to be re-
duced or functionally depleted [12,13]. Overall, the results
from these experiments support that bone marrow has
stem and progenitor cells that can stimulate wounds and
contribute to healing [3,5].
Figure 2 Effects of WBM, BMC and MSC on fibroblast migration in a ‘wound’ scratch assay. (A) Schematic diagram of the transwell
migration assay: Fibroblasts cells were plated in the lower chamber. Cell monolayers were mechanically disrupted with a 1 mL pipette tip. In
the upper chamber, the cells (WBM and MSC) were allowed to migrate for 24, 48 and 72 hours toward the lower chamber. Photographs
were taken at 0, 24, 48 and 72 hours to examine the defect in closing. (B) Photographs of wounded mouse fibroblast monolayers at 0, 24,
48 and 72 hours after wounding. (C) Scratch assays quantification in a wound-healing model. Effects of bone marrow derived cells on
mouse fibroblast migration in a wound scratch assay. In order to determine the percentage scratch closure the cell free space was measured
using cellSens software installed in an Olympus microscope and pixels were converted to micrometers. The migration value was calculated
as wound closure distance from time zero to 24, 48 and 72 hours respectively (Δd = dt0-d72h). The in vitro wound-healing assay showed that
WBM strongly improved the fibroblast wound closure compared with BMC, MSC and the control group. In this experiment the data
represent mean +/− SEM of five measurements. BMC, whole bone marrow cultured cells; MSC, mesenchymal stem cells; SEM, standard error
of the mean; WBM, whole bone marrow.
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The multifunctional properties of bone marrow-derived
cells, including their ability to differentiate into various
cell types and capacity to secrete factors important in ac-
celerating healing of cutaneous wounds, have made thesearch for a particular stem cell to orchestrate repair an
important goal. Mesenchymal stem cells derived from
bone marrow have become a promising agent for tissue
repair and regeneration and are the focus of numerous
clinical studies. It has been reported that BM-MSC could
Figure 3 Classical and reverse model of wounding procedure in mice. (A) Diagram with classical and reverse wound model procedure. In
the classical model the 8 mm punch is made 30 days after irradiation and in the reverse model the 8 mm punch is created between the two
cycles of radiation. (B) Wound healing is expressed as percentage closure relative to original size (1-(wound area on day x)/(wound area on day
0)) x100. The reverse model showed lower percentage closure at all time points compared to the classical model. P <0.05 indicates a statistically
significant difference in wound area between the reverse and classical models. All values are expressed as the mean and SEM. Each group
comprised 12 animals (n = 12). SEM, standard error of the mean.
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cells and recruit dermal fibroblasts to the wound site by
paracrine signaling [12].
Wounding, however, stimulates the recruitment of
several types of bone marrow derived cells to the skin
including inflammatory cells and vascular progenitor
cells. Some recent evidence supports that bone marrow
might also serve as a resource to provide skin progenitor
cells [5]. Given the uncertainty of which bone marrow
cells might be required at each phase of tissue repair and
regeneration, a mixed cell approach might then be more
useful. To help answer these questions, we began by exam-
ining three bone marrow cell preparations in two in vitro
assays examining angiogenesis and migration.
During the early stages of skin wound healing, angio-
genesis is fundamental for the effective development of
dermal tissue and is a hallmark of an established healing
response. With new blood vessel growth, steps involving
dissolution of basement membrane underlying endothelial
cells, endothelial cell migration, adhesion, proliferationand tube differentiation are required [14-16]. More-
over, the vasculature comprises up to 60% of repair tis-
sue in a wound, and the newly established blood
supply is required to meet the metabolic demands of
wound repair as well as to deliver needed repair cells
from distant sites. All these elements support the im-
portance of angiogenesis and vascularization in wound
repair. In our studies we examined three clinically uti-
lized cell preparations to evaluate their role in wound
repair. We found that WBM was able to achieve higher
new vessel tube formation compared with BMC and
MSC. This implies a potential significant advantage for
WBM to stimulate endothelial cells and angiogenesis
in tissue repair.
Cell migration is another crucial event in cutaneous
wound healing. Secreted factors are certain to be critical
in stimulating cell migration and, if optimized, could be
an essential component in developing improved thera-
peutics for wound healing. The in vitro scratch wound
assays using WBM, BMC and BM-MSC demonstrated
Figure 4 Effects of WBM, BMC and MSC on the in vivo wound closure in the mouse model and analysis of wounds. (A) Representative
photographs of the mouse excisional reverse model after transplantations of BMC, WBM, MSC and control vehicle at 0, 7 and 15 days. (B)
Epithelialization for each group after transplantations of BMC, WBM, MSC and control vehicle is expressed as percentage closure relative to the
original size (1-(wound area on day x)/(wound area on day 0)) x100. WBM treated wounds featured greater percentage closure at all time points
compared to BMC and MSC. Data represent mean +/− SEM of five measurements. Each group comprised 12 animals (n = 12). P <0.01 indicates a
statistically significant difference in wound closure between animals treated with WBM or BMC compared to animals treated with MSC and
control group. BMC, whole bone marrow cultured cells; MSC, mesenchymal stem cells; SEM, standard error of the mean; WBM, whole
bone marrow.
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ences dermal fibroblast migration. Here again, WBM ap-
peared superior to cultured cells. It could be that WBM,
having a greater mixed population of cell types than
BMC or BM-MSC, was capable of producing a more
wide-ranging cytokine profile that more closely resem-
bled that seen in healing wounds. Cultured bone marrow
cells, however, have shown benefit in chronic wounds
[2]. Dermal cells derived from these wounds typically
demonstrate evidence of senescence and lack of re-
sponse to growth factors [17,18]. We have previously
shown that BM-MSC stimulates chronic wound fibro-
blast to migrate [12]. The murine base scratch assay per-
formed in this study might not be representative enough
of human chronic wound fibroblasts to fully evaluate the
effect of cultured bone marrow cells on difficult to heal
wounds.
To examine the effect of WBM, BMC and BM-MSC
in vivo, we investigated two murine models of delayed
wound healing. Epithelialization, granulation tissue for-
mation, scar formation, contraction and angiogenesis are
seen in both humans and mice. Wound healing in mice,
however, occurs quite rapidly due in part to their greater
ability to heal by contraction [19,20]. Human chronic
wounds, unlike wounds in mice, are significantly re-
duced in resident stem cells [21]. Patients with chronic
wounds also have been shown to have abnormalities in
their bone marrow cells [2,10,22]. In this study, we
wished to create a murine model that would be depleted
of resident stem cells and demonstrate prolonged wound
closure. Gamma irradiation of mice has been used as an
effective tool for depleting stem cells [23,24]. Fraction-
ated total body irradiation has long been used to par-
tially ablate resident bone marrow (and other) stem cells
and ensure the survival of mice (Figure 3A) [23]. In the
classical model we performed fractional irradiation and
then allowed a 30-day period before wounding. During
the resting period between irradiation and wounding,
much of the depletion in the bone marrow compartment
would be expected to have recovered with engraftment
of the administered bone marrow cells (as demonstrated
by FACS analysis). The wounds in this model, however,
were delayed in closure compared to control mice indi-
cating that there still was a localized cutaneous radiation
effect. In the reverse model, wounding was performed
between the first and second doses of radiation. Wound
closure in these animals was significantly slower than in
the classical model. This was not entirely unexpected, as
a recovery period was not allowed prior to wounding.
It is also probable that further irradiation following the
stimulatory effects of acute wounding led to additional
depletion of local stem and progenitor cells that might
not have been so susceptible to radiation in resting skin.
The more acute effects of depletion in the bone marrowcompartment in the reverse model also cannot be ig-
nored. It is, however, remarkable that wound closure
was still delayed more than two weeks after irradiation
when recovery in the bone marrow compartment should
be expected to be occurring. In many ways it was felt
that the reverse model shared phenotypic changes seen
in chronic wounds, including depletion of resident stem
cells, abnormalities in bone marrow function and de-
layed healing. We, therefore, chose to test the ability of
WBM, BMC and BM-MSC to improve wound closure in
the reverse model.
WBM, BMC or BM-MSC was given to reverse model
treated mice by tail vein injection 24 hours after the sec-
ond radiation dose. There was an improvement in
wound closure for all cell preparations over the control
(untreated mice). As in previous experiments, however,
WBM appeared to be superior in achieving a more rapid
wound closure than were cultured cells. Also similar to
previous experiments, BMC appeared to have an advan-
tage over BM-MSC. A criticism for the reverse model
could be that WBM and BMC contained cells more cap-
able of restoring the bone marrow compartment than
BM-MSC. This, however, does not appear to fully ex-
plain the benefit of administering a mixed bone marrow
cell population such as WBM or BMC as these prepara-
tions performed better in both angiogenesis and migration
assays. It is also very unlikely that significant reconstitu-
tion of the bone marrow compartment could have taken
place in the first seven days when WBM and BMC
showed their greatest effect. What the reverse model ex-
periment may be indicating is the importance of mixed
bone marrow stem and progenitor cells in a setting where
they are locally and systemically impaired, such as in the
case of patients with multiple comorbidities and poorly
healing wounds.
Bone marrow derived cells are certain to play many
roles in the wound healing process. One role is based on
the capacity of bone marrow cells to secrete a variety of
growth factors and cytokines that are required to orches-
trate tissue repair and regeneration. This mechanism
would regulate cellular processes, such as chemotaxis,
cell proliferation, angiogenesis, extracellular matrix pro-
duction and remodeling. Another role is for bone mar-
row derived cells to differentiate into multiple cell types,
including fibroblast myofibroblasts and myoblasts after
migrating to the injury site [25]. The use of different
types of stem cells has emerged as a promising strategy
in regenerative medicine.
Multiple candidate cells have been used in preclinical
animal models and in humans to repair or regenerate the
injured tissue either directly or indirectly (through para-
crine effects), including: embryonic stem cells, induced
pluripotent stem cells, endothelial stem cells, bone mar-
row mononuclear stem cells, and mesenchymal stem cells.
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cells, such as mesenchymal stem cells, secrete a broad
spectrum of angiogenic or anti-apoptotic cytokines, which
play a role in the process of tissue repair and that BM-
MSC conditioned medium has been shown to contain the
majority of human cytokines fundamental in wound heal-
ing [26,27]. The faster wound closure in WBM compared
with BMC and MSC observed in our studies could suggest
a higher number of cytokines and growth factors in these
cells, which are essential in tissue repair. The results of
these experiments support the use of a mixture of cells
types in designing clinical approaches to wound healing.
Nevertheless, future studies to characterize and compare
the cytokines and cell types present in these cells should
be done.
Conclusions
We have shown that WBM is more efficient compared
to BMC and MSC in stimulating angiogenesis in vitro,
inducing fibroblast migration by paracrine effects and
in reducing wound size in a murine model of delayed
wound healing. Our studies demonstrate that mixed
bone marrow cell preparations may be superior to a
more purified stem cell formulation in stimulating wound
healing.
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